• Beth T Webber, Anthony L Panos, and Yiliam F Rodriguez-Blanco.
• Department of Anesthesia, Division of Cardiovascular Anesthesia, University of Miami, Florida, USA.
• Ann Card Anaesth. 2016 Jan 1; 19 (1): 192-6.

AbstractA growing number of patients are undergoing prolonged management of advanced heart failure with the use of continuous flow left ventricular assist devices (LVADs). Subsequently, an increasing number of patients are presenting with complications associated with these devices. Based on an analysis of three major LVAD institutions, the number of patients developing LVAD pump thrombosis may be much higher than originally projected. [1],[2] The management of this highly feared complication continues to be challenging, as the population of LVAD patients is very heterogeneous and heavily burdened with comorbidities. The standard protocol of increasing anticoagulation may fail to achieve successful resolution of thrombus. Difficulty and poor prognosis may make reoperation less than desirable. Here, we present a case of successful thrombolysis following intravenous administration of tissue plasminogen activator in the Intensive Care Unit setting.

21 keywords...

hide…